Mon, Jul 28, 2014, 4:59 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Amgen, Inc. (AMGN) Message Board

mirror_world_man 1373 posts  |  Last Activity: Jun 26, 2014 12:28 PM Member since: Mar 23, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • 'bout sums it up..

    Sentiment: Strong Buy

  • Reply to

    Phase 3 is likely

    by mirror_world_man Apr 29, 2014 12:40 PM
    mirror_world_man mirror_world_man Jun 20, 2014 5:48 PM Flag

    Yep. Even more likely now.

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Jun 9, 2014 9:20 PM Flag

    two generics placed together is a breakthrough? Doctors in NA general do not initiate dual therapy, they want the flexibility to taper individual doses due to AE's or response rates...Patients usually must be stable long term before physicians Rx the combo. Check out hypertensive combos with HCTZ etc., or combo therapy in Diabetes... This is yet another piece piece of hit pulp to help the shorts cover, time to pick up some more, the low 5.8's were nice for us early bird buyers...

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Jun 8, 2014 12:51 PM Flag

    announcements made in Vancouver, Canada of new WF stores. Existing stores are showing phenomenal cutomer loyalty and sales as there is no competition for this grocers business model

    Sentiment: Strong Buy

  • mirror_world_man mirror_world_man Jun 7, 2014 3:38 PM Flag

    Did you see the shorts attempt at hitting the hornets nest on Friday with that anonymous Red Flag pulp from seeking alpo? Not sure how many nuts fell from the tree they shook, but be prepared for similar negative articles followed by covering attempts. Hold shares. I don't have much to go on, but IMO the shorts may be losing operating cash to keep dumping shares and now are a little more desperate. Articles like that, laughable at its transparent attempts to scare retail.

    Sentiment: Strong Buy

  • Reply to

    Summary of Shady and Anonymous Article Today

    by bockmeister2 Jun 6, 2014 4:08 PM
    mirror_world_man mirror_world_man Jun 6, 2014 4:31 PM Flag

    IMHO. Shorts have made some bad investments in BT's recently and are running out of operating cash. Artificial volumes are down in many BTstocks that are creeping higher, and today's desperate article adds some credence..

    Sentiment: Strong Buy

  • mirror_world_man mirror_world_man Jun 6, 2014 4:06 PM Flag

    Well said collector. Originally I thought this desperate pulp from More Fool was to hit the weekly 6 puts, as odd as that sounds, not I think its merely a scare tactic to cover. Retail that has been around this long, will hold regardless,

    Sentiment: Strong Buy

  • mirror_world_man mirror_world_man Jun 5, 2014 3:54 PM Flag

    Shorts are busy churning elsewhere, WFM MNKD BMRN etc. They must be short of cash to dump everywhere ...

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Jun 5, 2014 2:20 PM Flag

    must not like where this is going... bass turds know how to bring a stock down but have no clue how to cover when the writing is on the wall.

    Sentiment: Strong Buy

  • Reply to

    June 5 calls

    by mirror_world_man Jun 4, 2014 2:52 PM
    mirror_world_man mirror_world_man Jun 5, 2014 12:42 PM Flag

    Oops! My mistake, I meant bullish.

    Sentiment: Strong Buy

  • Reply to

    So much for IBB correlations!

    by itsahorserace Jun 4, 2014 1:26 PM
    mirror_world_man mirror_world_man Jun 4, 2014 2:56 PM Flag

    Bought some Oct 5 calls, what the heck...

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Jun 4, 2014 2:52 PM Flag

    nobody wants my bids, interest over 1400 but minuscule volume. I take it as slightly bearish...

    Sentiment: Strong Buy

  • mirror_world_man mirror_world_man Jun 4, 2014 1:13 PM Flag

    Delisting noticed for NASDAQ occur if stock trades under $1 for a period of time. I think it is 3 months or so.

  • Reply to

    Turn around of biotech needed

    by dghurt66 Jun 3, 2014 12:34 PM
    mirror_world_man mirror_world_man Jun 3, 2014 11:47 PM Flag

    yep. My NAVB, CYTK, SGYP, BMRN,ARNA seem to have some solidarity unit bouncing off lows...Shorts can only maintain that kind of pressure for so long without selling volumes before carrying costs start accumulating to ridiculous levels..

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Jun 3, 2014 12:18 PM Flag

    Market Maker Shares Bid Price Ask Price Shares Market Maker
    Archipelago Stock Exchange 300 4.650 4.660 100 Direct Edge ECN LLC
    Bats Trading, Inc. 100 4.650 4.660 940 Nasdaq Execution Services, LLC.
    200 4.650 4.670 600 Archipelago Stock Exchange
    Boston Stock Exchange 100 4.650 4.670 100 Bats Trading, Inc.
    Direct Edge ECN LLC 200 4.650 4.670 100
    Direct Edge ECN LLC 500 4.650 4.670 100 Direct Edge ECN LLC
    Nasdaq Execution Services, LLC. 2,145 4.650 4.670 100 Timber Hill LLC
    Philadelphia Stock Exchange 200 4.650 4.680 100 Boston Stock Exchange
    Timber Hill LLC 100 4.580 4.690 100 Philadelphia Stock Exchange
    MORGAN STANLEY & CO. LLC 100 4.530 4.840 100 MORGAN STANLEY & CO. LLC
    LATOUR TRADING LLC 100 4.460 4.860 100 LATOUR TRADING LLC
    Knight Capital Americas LLC 100 4.380 4.920 100 Knight Capital Americas LLC
    Credit Suisse Securities (USA) LLC 100 4.330 4.940 100 Susquehanna Financial Group, LLP
    Goldman, Sachs & Co. 100 4.320 4.940 100 Susquehanna Capital Group

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Jun 3, 2014 9:44 AM Flag

    Market Maker Shares Bid Price Ask Price Shares Market Maker
    300 4.070 4.080 400 Nasdaq Execution Services, LLC.
    Direct Edge ECN LLC 100 4.070 4.090 100 Archipelago Stock Exchange
    Nasdaq Execution Services, LLC. 620 4.070 4.090 100 Bats Trading, Inc.
    Archipelago Stock Exchange 100 4.060 4.090 100
    Bats Trading, Inc. 100 4.060 4.110 200 Direct Edge ECN LLC
    Boston Stock Exchange 900 4.030 4.120 100 Philadelphia Stock Exchange
    Direct Edge ECN LLC 1,100 4.030 4.130 100 Timber Hill LLC
    Philadelphia Stock Exchange 100 4.020 4.140 900 Boston Stock Exchange
    Citigroup Global Markets Inc. 100 4.010 4.140 900 Direct Edge ECN LLC
    AUTOMATED TRADING DESK FINANCIAL SERVICES, LLC 100 4.000 4.140 100 Citigroup Global Markets Inc.
    Timber Hill LLC 100 3.980 4.270 100 Knight Capital Americas LLC
    LATOUR TRADING LLC 100 3.860 4.270 100 LATOUR TRADING LLC
    Knight Capital Americas LLC 100 3.810 4.360 100 The Vertical Trading Group, LLC
    UBS Securities LLC 500 3.800 4.370 100 Susquehanna Capital Group
    The Vertical Trading Group, LLC 100 3.780 4.500 100 AUTOMATED TRADING DESK FINANCIAL SERVICES, LLC

    Sentiment: Strong Buy

  • Reply to

    Plecanatide 9.7% diarrhea vs Linzess 20%

    by betonbio Jun 1, 2014 11:12 PM
    mirror_world_man mirror_world_man Jun 3, 2014 12:38 AM Flag

    Cannot compare two diifferent study populations unless they are in the same study, only head to head can do that. Wish for it

    Sentiment: Strong Buy

  • Reply to

    Broads with Big Knockers

    by gobelviq Jun 2, 2014 5:13 PM
    mirror_world_man mirror_world_man Jun 2, 2014 5:28 PM Flag

    Sure enough, but ask the doctor what the rep with the bazookas said and the Doctor always says "she said something ?" Lol. With new product launches in new classes, it pays to have class.

    Sentiment: Strong Buy

  • Its a hard and durable endpoint linked to prolonged survival. WS may know how to short a stock, but they know nothing about shortness if breath. If this was a primary endpoint, stock would soar right now. a new trial will emerge, with better nutritional monitoring, pulmonary endpoints, symptom scorecards. Hold or add on thisdip...

    Sentiment: Strong Buy

  • Merck presents early findings from Phase 1b study for pembrolizumab
    Merck announced the first presentation of early findings from a Phase 1b study evaluating pembrolizumab, MK-3475, Merck’s investigational anti-PD-1 antibody, as a single-agent, monotherapy, in patients with PD-L1 positive, advanced head and neck cancer. Early data showed a best overall response rate of 20% with 29% of patients having stable disease as measured by RECIST criteria . Similar overall response rates were observed in Human papillomavirus, HPV-positive and HPV-negative patients – HPV infection is a risk factor for some types of head and neck cancer. In the study, tumor shrinkage was demonstrated in 51% of evaluable patients who had measurable disease with one post baseline scan, per RECIST criteria. These early findings will be presented in an oral session by Dr. Tanguy Seiwert, associate director of the Head and Neck Cancer Program and assistant professor of medicine at The University of Chicago, at the 50th Annual Meeting of the American Society of Clinical Oncology. “Recurrent and metastatic head and neck cancer carries a very poor prognosis, and often is accompanied by poor quality of life and disfigurement. Additional treatment options are urgently needed,” said Dr. Seiwert. “These early response data with pembrolizumab as monotherapy provide an encouraging proof of concept and support further study of this novel investigational immunotherapy in this hard-to-treat cancer type.” “We continue to observe robust signals of anti-tumor activity in response to pembrolizumab monotherapy across multiple tumor types and lines of therapy, including these data in head and neck cancer,” said Dr. Roy Baynes, senior vice president, global clinical development, Merck Research Laboratories. “The breadth of data to be presented at ASCO underscores why Merck is advancing a broad development program for pembrolizumab across more than 30 tumor types, including late-stage studies in head and neck and othe

    Sentiment: Strong Buy

AMGN
122.65-0.19(-0.15%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.